The report named Specialty Enzymes Market Research Report, published by Stratview Research offers a thorough knowledge of the development and current scenario of the market. This report contains updated information related to the market gathered by extensive primary and secondary research. The market report incorporates the key players including manufacturers, providers, etc. This can help the users to understand the scenario of the market and take a firm decision for future investments.
Market Insights
This newly published and insightful report sheds light on market insights of the Specialty Enzymes Market, including their impact on the overall value chain from suppliers to end-users and growth dynamics. Also, it discusses the market size from 2022-2028.
As per the report, the specialty enzymes market size was valued at USD 4.82 billion in 2021 and is likely to grow at a CAGR of 7.06% during 2022-2028 to reach USD 7.8 billion in 2028.
Market Drivers
• The present surge in the non-hazardous biological catalysts in pharmaceuticals and diagnostics,
• The advanced development in tools to maximize pharmaceutical production & quality,
• Multi-functional advantages of specialty enzymes.
Key Players
Stratview Research tracks all the major product launches, mergers and acquisitions over the past few years. The idhentification of key players in the market is based on both primary interview results as well as available authentic secondary data sources. According to the research, the following are the key players in the Specialty Enzymes Market.
• BASF SE
• Novozymes A/S
• Roche Holding
• DuPont de Nemours, Inc
• Codexis Inc.
• Dyadic International
• Advanced Enzymes
• Amano Enzyme
• Sanofi
• Biocatalysts.
This report aims at providing critical market information and valuable insights which are of high value to the users, enabling them to identify the strategic growth opportunities in the market. The report also aims at answering the following key questions:
- What is the current and future market potential of the Specialty Enzymes Market?
- How will the COVID-19 pandemic impact the market?
- What will be the short and long-term repercussions of the pandemic?
- How are other crucial market factors changing the market dynamics?
- When is the recovery expected from the pandemic?
- After the pandemic, which region will heal up with the fastest pace?
- Which segments offer high-growth opportunities in the long run?
- How fierce is the market competition?
- What are the key emerging trends and unmet needs?
- What are the strategic growth opportunities and key success factors?
Segments Analysis
Based on the type, the market is segmented as carbohydrases, proteases, lipases, polymerases & nucleases, and others. The polymerases & nucleases segment is expected to dominate the market during the forecast period, owing to their usage in special applications such as pharmaceuticals, research & biotechnology, diagnostics, and biocatalysts.
Also, being the essential parts for all nucleic acid processing including replication, repair, recombination & transcription, makes they support the catalysis of the synthesis of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) polymers, ushering the segment towards unprecedented growth.
Based on the application type, the specialty enzymes market is segmented as pharmaceuticals, research & biotechnology, diagnostics, and biocatalysts. The pharmaceuticals segment dominates the market, owing to the increase in its application in the pharmaceutical industry, mainly for drug manufacture, disease diagnostics, or as therapy. There has been an increase in the usage of specialty enzymes for therapies such as cancer, cardiovascular diseases, lysosomal storage disorders, and pain and inflammation management, which also acts as a driving factor for the growth of the segment.
Based on the source type, the market is segmented into microorganisms, plants, and animals. The microorganisms segment is expected to grow at the highest growth rate, as enzymes extracted from microbial sources lead to low production costs, can be cultured in large quantities in a short period of time, and contain more predictable and controllable enzyme content.
In terms of regions, North America is estimated to be the largest-growing market for specialty enzymes during the forecast period. Technological advancements, the availability of enzymes for a wide range of applications, the development of novel & superior-performing products, and global industrialization are driving the region’s market, along with an increase in the usage of enzymes in the region’s pharmaceutical industry. Further, the US is estimated to be the dominant market in the North American region and is at the stage to reach maturity very sooner.
About Us –
Stratview Research is a growing market research firm. Experts here illustrate innovative, descriptive, and comprehensive insights through market research to satisfy your individual and organizational objectives. We assist the users to make well-informed, profound and favourable decisions to comprehend the advantages of forthcoming trends, developments, assessments, and opportunities through our precise understanding of the market. You may also connect with our market experts at [email protected] or +1-313-307-4176.